CVRx/$CVRX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About CVRx
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
Ticker
$CVRX
Sector
Primary listing
Employees
223
Headquarters
Website
CVRx Metrics
BasicAdvanced
$131m
-
-$2.01
0.87
-
Price and volume
Market cap
$131m
Beta
0.87
52-week high
$11.30
52-week low
$4.37
Average daily volume
354k
Financial strength
Current ratio
10.199
Quick ratio
8.582
Long term debt to equity
202.803
Total debt to equity
204.043
Interest coverage (TTM)
-8.44%
Profitability
EBITDA (TTM)
-49.212
Gross margin (TTM)
86.18%
Net profit margin (TTM)
-89.15%
Operating margin (TTM)
-84.62%
Effective tax rate (TTM)
0.02%
Revenue per employee (TTM)
$260,000
Management effectiveness
Return on assets (TTM)
-27.25%
Return on equity (TTM)
-106.96%
Valuation
Price to revenue (TTM)
2.196
Price to book
4.49
Price to tangible book (TTM)
4.49
Price to free cash flow (TTM)
-3.23
Free cash flow yield (TTM)
-30.96%
Free cash flow per share (TTM)
-1.532
Growth
Revenue change (TTM)
11.73%
Earnings per share change (TTM)
-7.38%
3-year revenue growth (CAGR)
30.84%
3-year earnings per share growth (CAGR)
-1.12%
What the Analysts think about CVRx
Analyst ratings (Buy, Hold, Sell) for CVRx stock.
CVRx Financial Performance
Revenues and expenses
CVRx Earnings Performance
Company profitability
CVRx News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs